BeStock  
Markets › Compare › TLX vs VKTX

TLX vs VKTX

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
TLX · Telix Pharmaceuticals$10.88 ▲ 3.13%
VKTX · Viking Therapeutics$29.28 ▼ 2.20%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

608099118138Oct 7, '25Apr 7, '26Oct 5, '26
  • TLX +9.3%
  • VKTX -7.2%

Head to head

MetricTLXVKTX
Price$10.88$29.28
Change today▲ 3.13%▼ 2.20%
Market cap$3.69B$3.68B
Return, 3 months-7.3%-30.5%
Return, year to date+45.3%-16.8%
Return, 1 year+6.9%-9.3%
P/E (TTM)112.2-6.3
P/B8.99.0
P/E percentile vs own 5y–81st
Dividend yield––
Revenue growth (YoY, latest qtr)––
Net profit growth (YoY)–-227.1%
Gross margin––
Operating margin––
Net margin––
Return on equity––
Analyst target vs. price+83.8%+209.0%
Analyst buy share100%94%
RSI (14)4541
30-day volatility68.5%108.4%
Max drawdown, 1 year-41.8%-35.5%
Trend readLeaning bearishStrong downtrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • TLX is the largest of the group by market value.
  • TLX has returned the most over the past year.
  • VKTX carries the lowest trailing P/E.
  • TLX has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top